AzTrials
AzTrials

Virtual RealityNCT07207083

Can Virtual Reality Exercise Help Restore Both Body and Mind in Chronic Low Back Pain

A study testing Immersive Virtual Reality-based Exercise (FitXR, Meta Quest 3s) and Conventional Exercise Program (Matched Exercise, without VR) in people with Virtual Reality and Kinesiophobia, run by dongmin kang at 1 site in South Korea.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if an immersive virtual reality (VR) exercise program can help reduce back pain and improve physical function and psychological well-being in adults with chronic low back pain. Read more about this study

Who is it for?
Ages 18 to 40 years
What is being tested?
Immersive Virtual Reality-based Exercise (FitXR, Meta Quest 3s) and Conventional Exercise Program (Matched Exercise, without VR)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteSouth Korea
Study dates
28 Sep 2025to 31 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age 18-40 years.
  • Non-specific chronic low back pain lasting ≥3 months.
  • Baseline pain intensity VAS ≥4/10.
  • Kinesiophobia (TSK-13) ≥34.
  • Able to perform physical activity using immersive VR (screened as suitable for head-mounted display-based activity).
  • Understands the study purpose and procedures and provides written informed consent.

Who cannot join

  • Severe pain making participation infeasible: VAS ≥8/10.
  • Lumbar spine surgery within the past 6 months.
  • Severe musculoskeletal disorders (e.g., advanced osteoarthritis, pathological vertebral fracture).
  • Neurological disorders (e.g., multiple sclerosis, Parkinson's disease, stroke).
  • Cardiovascular disease (e.g., heart failure, clinically significant arrhythmia, recent myocardial infarction).
  • Simulator Sickness Questionnaire (SSQ): total score ≥20 or any single item scored 3.
  • Vulnerable populations excluded: minors, older adults, individuals with psychiatric disorders or cognitive impairment, and pregnant persons.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

South Korea1 site
  • Sahmyook University, Science Hall 3

    Seoul, Seoul, 01795

Other trials in South Korea

About this study

Official title: Effects of Immersive Virtual Reality-based Exercise on Somatosensory Function, Pain, and Psychological and Functional Recovery in Patients With Chronic Low Back Pain

The goal of this clinical trial is to learn if an immersive virtual reality (VR) exercise program can help reduce back pain and improve physical function and psychological well-being in adults with chronic low back pain.

The main questions it aim to answer are

Read more
  • Does the virtual reality (VR) exercise reduce back pain?
  • Does it lead to positive changes in how participants perceive pain?
  • Does it improve back flexibility and reduce disability in daily activities?
  • Does it help reduce the fear of movement and negative thoughts related to pain? Method Wear a Meta Quest 3s device and participate in a 15-minute virtual reality exercise program called 'FitXR'.

Be evaluated for their back pain, sensory test, range of motion, and level of disability in daily life before and after the exercise program.

Complete questionnaires about their thoughts and feelings regarding their pain and movement.

Being tested
Immersive Virtual Reality-based Exercise (FitXR, Meta Quest 3s), Conventional Exercise Program (Matched Exercise, without VR)
Medical subject headings
Kinesiophobia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Immersive Virtual Reality-based Exercise (FitXR, Meta Quest 3s)Behavioural

    participants assigned to the intervention group will perform a 15-minute immersive virtual reality (VR) exercise program using the FitXR application on the Meta Quest 3s headset.

    This program provides interactive, visually immersive exercise tasks designed to engage participants in physical activity while reducing fear of movement and enhancing functional recovery.

  • Conventional Exercise Program (Matched Exercise, without VR)Behavioural

    Participants assigned to this arm will perform the same 15-minute exercise program without virtual reality equipment.

    This allows comparison between immersive VR-based exercise and conventional exercise of equivalent intensity and duration.

Study groups in NCT07207083
Study groupRoleWhat they receive
VR Exercise GroupExperimentalParticipants perform a 15-minute exercise program using immersive virtual reality (FitXR app with Meta Quest 3s).
Receives: Behavioral: Immersive Virtual Reality-based Exercise (FitXR, Meta Quest 3s)
Non-VR Exercise GroupActive comparatorParticipants perform the same 15-minute exercise program, but without VR equipment.
Receives: Behavioral: Conventional Exercise Program (Matched Exercise, without VR)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quantitative Sensory Testing (QST): Specifically including Conditioned Pain Modulation (CPM) and Temporal Summation (TS) protocols.

    CPM measures the efficiency of the body's pain-inhibiting pathways. A higher positive value indicates a more effective pain modulation system (better outcome). TS measures pain sensitization. A higher score indicates greater central sensitization to pain (worse outcome).

    Measured: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).

Secondary outcomes (6)
  1. Tampa Scale for Kinesiophobia-13 (TSK-13)

    The scale scores range from 13 to 52. A higher score indicates a greater degree of kinesiophobia (fear of movement), which is a worse outcome.

    Measured: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).

  2. Pain Catastrophizing Scale (PCS)

    The scale score ranges from 0 to 52. A higher score indicates a greater level of pain catastrophizing (a worse outcome).

    Measured: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).

  3. Oswestry Disability Index (ODI)

    This index measures disability due to low back pain, with the score reported as a percentage from 0% to 100%. A score of 0% indicates no disability, while 100% indicates the most severe disability (a worse outcome).

    Measured: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).

  4. Fear-Avoidance Beliefs Questionnaire (FABQ)

    This questionnaire has two subscales: Physical Activity (range 0-24) and Work (range 0-42). For both scales, a higher score indicates stronger fear-avoidance beliefs (a worse outcome).

    Measured: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).

  5. Visual Analog Scale (VAS)

    This scale measures the intensity of pain. It is typically a 100-millimeter line on which participants mark their pain level. A score of 0 mm indicates "no pain", while 100 mm indicates "the worst pain imaginable". A lower score represents a better outcome.

    Measured: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).

  6. Lumbar Range of Motion (ROM)

    This is a physical measurement of lumbar spine flexibility, objectively assessed using a dual inclinometer. The range of motion for flexion, lateral bending is reported in degrees (°). A higher value, representing a greater range of movement, indicates better physical function (a better outcome).

    Measured: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2025
  2. Study start28 Sep 2025
  3. Primary completion16 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to one of two parallel groups. The experimental group will perform immersive Virtual Reality-based exercise using the FitXR application, while the control group will perform the same exercise protocol without VR immersion. Both groups will receive 15-minute exercise sessions over the study period.
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07207083
Sponsor's protocol ID
SYU 2025-08-019-002
Status last verified
Nov 2025
First submitted
26 Sep 2025
Last updated
5 Dec 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Immersive Virtual Reality-based Exercise (FitXR, Meta Quest 3s) and Conventional Exercise Program (Matched Exercise, without VR) in people with Virtual Reality and Kinesiophobia, run by dongmin kang at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 5 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quantitative Sensory Testing (QST): Specifically including Conditioned Pain Modulation (CPM) and Temporal Summation (TS) protocols. (time frame: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT07207083 | AzTrials